Premium
Is the life‐long entecavir treatment really inevitable in chronic hepatitis B patients?
Author(s) -
Zeng Wanjia,
Liu Mingchen,
Peng Siwen,
Yu Guangxin,
Zhai Xiangwei,
Chen Xiangmei,
Lu Fengmin
Publication year - 2020
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.13369
Subject(s) - beijing , health science , china , medicine , infectious disease (medical specialty) , medical science , family medicine , library science , public health , biomedical sciences , medical school , center (category theory) , entecavir , epidemiology , disease , medical education , political science , virology , chronic hepatitis , pathology , chemistry , virus , lamivudine , law , computer science , crystallography